Advertisement
Policy Matters| Volume 28, ISSUE 2, P137-143, March 2018

Rethinking Medicaid Coverage and Payment Policy to Promote High Value Care: The Case of Long-Acting Reversible Contraception

  • Author Footnotes
    † Veronica X. Vela and Elizabeth W. Patton are considered co-first authors of this paper.
    Veronica X. Vela
    Correspondence
    Correspondence to: Veronica X. Vela, MS, IEOR, DrPH(C), George Washington University, Center for Health Policy Research, Department of Health Policy and Management, Milken Institute School of Public Health, 2175 K Street NW, 5th Floor, Washington, DC 20037. Phone: +(202) 594-6394; fax: +(202) 994-3500.
    Footnotes
    † Veronica X. Vela and Elizabeth W. Patton are considered co-first authors of this paper.
    Affiliations
    Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Center for Health Policy Research, Washington, DC
    Search for articles by this author
  • Author Footnotes
    † Veronica X. Vela and Elizabeth W. Patton are considered co-first authors of this paper.
    Elizabeth W. Patton
    Footnotes
    † Veronica X. Vela and Elizabeth W. Patton are considered co-first authors of this paper.
    Affiliations
    Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston, Massachusetts
    Search for articles by this author
  • Darshak Sanghavi
    Affiliations
    OptumLabs, Cambridge, Massachusetts
    Search for articles by this author
  • Susan F. Wood
    Affiliations
    Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Center for Health Policy Research, Washington, DC

    Jacobs Institute of Women's Health, Milken Institute School of Public Health, George Washington University, Washington, DC
    Search for articles by this author
  • Peter Shin
    Affiliations
    Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Center for Health Policy Research, Washington, DC

    Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University, Washington, DC
    Search for articles by this author
  • Sara Rosenbaum
    Affiliations
    Center for Health Policy Research, Milken Institute School of Public Health, George Washington University, Washington, DC
    Search for articles by this author
  • Author Footnotes
    † Veronica X. Vela and Elizabeth W. Patton are considered co-first authors of this paper.
Published:January 09, 2018DOI:https://doi.org/10.1016/j.whi.2017.10.013

      Abstract

      Context

      Long-acting reversible contraception (LARC) is the most effective reversible method to prevent unplanned pregnancies. Variability in state-level policies and the high cost of LARC could create substantial inconsistencies in Medicaid coverage, despite federal guidance aimed at enhancing broad access. This study surveyed state Medicaid payment policies and outreach activities related to LARC to explore the scope of services covered.

      Methods

      Using publicly available information, we performed a content analysis of state Medicaid family planning and LARC payment policies. Purposeful sampling led to a selection of nine states with diverse geographic locations, political climates, Medicaid expansion status, and the number of women covered by Medicaid.

      Results

      All nine states' Medicaid programs covered some aspects of LARC. However, only a single state's payment structure incorporated all core aspects of high-quality LARC service delivery, including counseling, device, insertion, removal, and follow-up care. Most states did not explicitly address counseling, device removal, or follow-up care. Some states had strategies to enhance access, including policies to increase device reimbursement, stocking and delivery programs to remove cost barriers, and covering devices and insertion after an abortion.

      Conclusions

      Although Medicaid policy encourages LARC methods, state payment policies frequently fail to address key aspects of care, including counseling, follow-up care, and removal, resulting in highly variable state-level practices. Although some states include payment policy innovations to support LARC access, significant opportunities remain.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aiken A.R.
        • Creinin M.D.
        • Kaunitz A.M.
        • Nelson A.L.
        • Trussell J.
        Global fee prohibits postpartum provision of the most effective reversible contraceptives.
        Contraception. 2014; 90: 466-467
        • Beeson T.
        • Wood S.
        • Bruen B.
        • Goldberg D.G.
        • Mead H.
        • Rosenbaum S.
        Accessibility of long-acting reversible contraceptives (LARCs) in federally qualified health centers (FQHCs).
        Contraception. 2014; 89: 91-96
        • Boulet S.L.
        Contraceptive use among nonpregnant and postpartum women at risk for unintended pregnancy, and female high school students, in the context of zika preparedness—United States, 2011–2013 and 2015.
        MMWR. Morbidity and Mortality Weekly Report. 2016; 65
        • Carlin C.S.
        • Fertig A.R.
        • Dowd B.E.
        Affordable Care Act's mandate eliminating contraceptive cost sharing influenced choices of women with employer coverage.
        Health Affairs (Project Hope). 2016; 35: 1608-1615
        • Centers for Medicare and Medicaid Services (CMS)
        Health care innovation awards round two. A contraceptive center of excellence: An innovative health services delivery and payment model.
        2016 (Available:) (Accessed: October 19, 2017)
        • Cleland K.
        • Peipert J.F.
        • Westhoff C.
        • Spear S.
        • Trussell J.
        Family planning as a cost-saving preventive health service.
        New England Journal of Medicine. 2011; 364: e37
        • de Bocanegra H.
        • Chang R.
        • Menz M.
        • Howell M.
        • Darney P.
        Postpartum contraception in publicly-funded programs and interpregnancy intervals.
        Obstetrics and Gynecology. 2013; 122: 296-303
        • Finer L.B.
        • Zolna M.R.
        Declines in unintended pregnancy in the united states, 2008–2011.
        New England Journal of Medicine. 2016; 374: 843-852
        • Garfield R.
        • Damico A.
        • Stephens J.
        • Rouhani S.
        The coverage gap: Uninsured poor adults in states that do not expand Medicaid–An update.
        Kaiser Family Foundation, Menlo Park, CA2016
        • Gavin L.
        • Moskosky S.
        • Carter M.
        • Curtis K.
        • Glass E.
        • Godfrey E.
        • Zapata L.
        Providing quality family planning services.
        MMWR Morbidity & Mortality Weekly Report. 2014; 63: 1-54
        • Greenberg K.B.
        • Makino K.K.
        • Coles M.S.
        Factors associated with provision of long-acting reversible contraception among adolescent health care providers.
        Journal of Adolescent Health. 2013; 52: 372-374
        • Harper C.C.
        • Blum M.
        • de Bocanegra H.T.
        • Darney P.D.
        • Speidel J.J.
        • Policar M.
        • Drey E.A.
        Challenges in translating evidence to practice: The provision of intrauterine contraception.
        Obstetrics and Gynecology. 2008; 111: 1359-1369
        • Health Resources and Services Administration
        340B drug pricing program.
        2017 (Available:) (Accessed: October 19, 2017)
        • Iglehart J.K.
        Desperately seeking savings: States shift more Medicaid enrollees to managed care.
        Health Affairs. 2011; 30: 1627
        • Kaiser Family Foundation
        Rate of Legal Abortions per 1,000 Women Aged 15-44 Years by State of Occurrence.
        2012 (Available:) (Accessed: October 19, 2017)
        • Kaiser Family Foundation
        State Political Parties.
        2016 (Available:) (Accessed: October 19, 2017)
        • Kaiser Family Foundation
        Status of State Action on the Medicaid Expansion Decision.
        2016 (Available:) (Accessed: October 19, 2017)
        • Mercier R.J.
        • Garrett J.
        • Thorp J.
        • Siega-Riz A.M.
        Pregnancy intention and postpartum depression: Secondary data analysis from a prospective cohort.
        BJOG: An International Journal of Obstetrics & Gynecology. 2013; 120: 1116-1122
        • Mestad R.
        • Secura G.
        • Allsworth J.E.
        • Madden T.
        • Zhao Q.
        • Peipert J.F.
        Acceptance of long-acting reversible contraceptive methods by adolescent participants in the contraceptive CHOICE project.
        Contraception. 2011; 84: 493-498
        • Mohllajee A.
        • Curtis K.
        • Marchbanks P.
        The impact of pregnancy intention on birth outcomes.
        American Journal of Epidemiology. 2004; 159: S88
        • Moniz M.H.
        • Chang T.
        • Davis M.M.
        • Forman J.
        • Landgraf J.
        • Dalton V.K.
        Medicaid administrator experiences with the implementation of immediate postpartum long-acting reversible contraception.
        Women's Health Issues. 2016; 26: 313-320
        • Moniz M.H.
        • Dalton V.K.
        • Davis M.M.
        • Forman J.
        • Iott B.
        • Landgraf J.
        • Chang T.
        Characterization of Medicaid policy for immediate postpartum contraception.
        Contraception. 2015; 92: 523-531
      1. New York State Department of Health. (2015). New York state family planning services frequently asked questions. Available: https://www.emedny.org/ProviderManuals/NYS_Medicaid_Family_Planning_FAQs_May_2015.pdf. Accessed: October 19, 2017.

        • Patient Protection Affordable Care Act
        USC § 18001(2010).
        2010 (Available:) (Accessed: October 19, 2017)
        • Potter J.E.
        • Hopkins K.
        • Aiken A.R.
        • Hubert C.
        • Stevenson A.J.
        • White K.
        • Grossman D.
        Unmet demand for highly effective postpartum contraception in Texas.
        Contraception. 2014; 90: 488-495
        • Ricketts S.
        • Klingler G.
        • Schwalberg R.
        Game change in Colorado: Widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women.
        Perspectives on Sexual and Reproductive Health. 2014; 46: 125-132
        • Romero L.
        • Pazol K.
        • Warner L.
        • Gavin L.
        • Moskosky S.
        • Besera G.
        Vital signs: Trends in use of long-acting reversible contraception among teens aged 15-19 years seeking contraceptive services—United States, 2005-2013.
        MMWR Morbidity and Mortal Weekly Reports. 2015; 64: 363-369
        • Sawhill I.V.
        Generation unbound: Drifting into sex and parenthood without marriage.
        Brookings Institution Press, Washington, DC2014
      2. Sonfield, A., & Kost, K. (2015). Public costs from unintended pregnancies and the role of public insurance programs in paying for pregnancy-related care: National and state estimates for 2010, New York: Guttmacher Institute. Available: http://www.guttmacher.org/pubs/public-costs-of-UP-2010.pdf. Accessed: October 19, 2017.

      3. Sonfield, A. (2016). CMS provides new clarity for family planning under Medicaid. Health Affairs Blog. Available: https://www.healthaffairs.org/do/10.1377/hblog20160712.055796/full/. Accessed: October 19, 2017.

      4. Sonfield, A., Hasstedt, K., & Gold, R. B. (2014). Moving forward: Family planning in the era of health reform. New York: Guttmacher Institute.

        • Sonfield A.
        • Gold R.B.
        Public funding for family planning, sterilization and abortion services, FY 1980-2010.
        Guttmacher Institute, New York2012: 1-19
        • Strasser J.
        • Borkowski L.
        • Couillard M.
        • Allina A.
        • Wood S.F.
        Access to removal of long-acting reversible contraceptive methods is an essential component of high-quality contraceptive care.
        Women's Health Issues. 2017; 27: 253-255
      5. Texas Health and Human Services. (2016). Texas vendor drug program long acting reversible contraceptive products. Available: https://www.txvendordrug.com/formulary/formulary/long-acting-reversible-contraception-products. Accessed: October 19, 2017.

        • U.S. Census Bureau
        Census regions and division of the United States.
        U.S. Government Printing Office, Washington, DC2010
        • U.S. Census Bureau
        Current population survey, annual social and economic supplement.
        U.S. Government Printing Office, Washington, DC2016
        • Ventura S.J.
        • Hamilton B.E.
        • Matthews T.J.
        National and state patterns of teen births in the United States, 1940–2013.
        National Vital Statistics Reports. 2014; 63: 1-34
        • Walls J.
        • Gifford K.
        • Ranji U.
        • Salganicoff A.
        • Gomez I.
        Medicaid coverage of family planning benefits: Results from a state survey.
        Kaiser Family Foundation, Menlo Park, CA2016
      6. Wood, S., Goldberg, D. G., Beeson, T., Bruen, B. K., Johnson, K., Mead, H., …, Rosenbaum, S. J. (2013). Health centers and family planning: Results of a nationwide study. Available: https://hsrc.himmelfarb.gwu.edu/sphhs_policy_facpubs/60. Accessed: October 19, 2017

      Biography

      Veronica X. Vela, MS, IEOR, DrPH(C), redesigns health care services for the Department of Veterans Affairs. She is a Human Innovation Fellow, Office of Personnel and Management Innovation Lab, and a doctoral candidate (George Washington University's Milken Institute School of Public Health).

      Biography

      Elizabeth W. Patton, MD, MPhil, MSc, is an Assistant Professor, obstetrician-gynecologist, and health services researcher at the Boston University School of Medicine/Boston Medical Center and the VA Boston Healthcare System.

      Biography

      Darshak Sanghavi, MD, is Chief Medical Officer and Senior Vice President of Translation at OptumLabs. Previously, he was the Director of Preventive and Population Health at the Center for Medicare and Medicaid Innovation within the U.S. Department of Health and Human Services.

      Biography

      Susan F. Wood, PhD, is a Professor of Health Policy and Management and Director of the Jacobs Institute of Women's Health, all at George Washington University. Previously she was Assistant Commissioner for Women's Health and Director of the Office of Women's Health at the FDA.

      Biography

      Peter Shin, PhD, MPH, is Director of the Geiger Gibson Program in Community Health Policy, RCHN Community Health Foundation Research Director, and an Associate Professor in the Department of Health Policy at the George Washington University Milken Institute School of Public Health.

      Biography

      Sara Rosenbaum, JD, is the Harold and Jane Hirsh Professor of Health Law and Policy, Founding Chair of the Department of Health Policy at the Milken Institute School of Public Health, and professor of Public Policy and Public Administration, Law, and Medicine, George Washington University.